Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Heymans, S; Hirsch, E; Anker, SD; Aukrust, P; Balligand, JL; Cohen-Tervaert, JW; Drexler, H; Filippatos, G; Felix, SB; Gullestad, L; Hilfiker-Kleiner, D; Janssens, S; Latini, R; Neubauer, G; Paulus, WJ; Pieske, B; Ponikowski, P; Schroen, B; Schultheiss, HP; Tschope, C; Van Bilsen, M; Zannad, F; McMurray, J; Shah, AM.
Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology.
Eur J Heart Fail. 2009; 11(2):119-129 Doi: 10.1093/eurjhf/hfn043 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG Google Scholar

 

Co-Autor*innen der Med Uni Graz
Pieske Burkert Mathias
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
The increasing prevalence of heart failure poses enormous challenges for health care systems worldwide. Despite effective medical interventions that target neurohumoral activation, mortality and morbidity remain substantial. Evidence for inflammatory activation as an important pathway in disease progression in chronic heart failure has emerged in the last two decades. However, clinical trials of 'anti-inflammatory' therapies (such as anti-tumor necrosis factor-alpha approaches) have to date failed to show benefit in heart failure patients. The Heart Failure Association of the European Society of Cardiology recently organized an expert workshop to address the issue of inflammation in heart failure from a basic science, translational and clinical perspective, and to assess whether specific inflammatory pathways may yet serve as novel therapeutic targets for this condition. This consensus document represents the outcome of the workshop and defines key research questions that still need to be addressed as well as considering the requirements for future clinical trials in this area.
Find related publications in this database (using NLM MeSH Indexing)
Animals -
Anti-Inflammatory Agents - therapeutic use
Antioxidants - therapeutic use
C-Reactive Protein - therapeutic use
Heart Failure - drug therapy Heart Failure - etiology Heart Failure - metabolism
Humans -
Immunologic Factors - therapeutic use
Inflammation -
Mannose-Binding Lectin - metabolism
Matrix Metalloproteinase Inhibitors -
Phosphatidylinositol 3-Kinases - antagonists and inhibitors
Serum Amyloid P-Component - therapeutic use

Find related publications in this database (Keywords)
Inflammation
Heart failure
Treatment
© Med Uni Graz Impressum